These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23734683)

  • 1. RGS17: an emerging therapeutic target for lung and prostate cancers.
    Bodle CR; Mackie DI; Roman DL
    Future Med Chem; 2013 Jun; 5(9):995-1007. PubMed ID: 23734683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures.
    Bodle CR; Schamp JH; O'Brien JB; Hayes MP; Wu M; Doorn JA; Roman DL
    SLAS Discov; 2018 Apr; 23(4):363-374. PubMed ID: 29351497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers.
    Hayes MP; Roman DL
    AAPS J; 2016 May; 18(3):550-9. PubMed ID: 26928451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel high-throughput screen and identification of small-molecule inhibitors of the Gα-RGS17 protein-protein interaction using AlphaScreen.
    Mackie DI; Roman DL
    J Biomol Screen; 2011 Sep; 16(8):869-77. PubMed ID: 21680864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.
    Kimple AJ; Bosch DE; Giguère PM; Siderovski DP
    Pharmacol Rev; 2011 Sep; 63(3):728-49. PubMed ID: 21737532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution structure of RGS17 suggests a role for Ca
    Sieng M; Hayes MP; O'Brien JB; Andrew Fowler C; Houtman JC; Roman DL; Lyon AM
    J Biol Chem; 2019 May; 294(20):8148-8160. PubMed ID: 30940727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: G Protein-coupled Receptors and RGS Proteins.
    Stewart A; Fisher RA
    Prog Mol Biol Transl Sci; 2015; 133():1-11. PubMed ID: 26123299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
    Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
    J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-based assays for RGS box function.
    Willard FS; Kimple RJ; Kimple AJ; Johnston CA; Siderovski DP
    Methods Enzymol; 2004; 389():56-71. PubMed ID: 15313559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macromolecular composition dictates receptor and G protein selectivity of regulator of G protein signaling (RGS) 7 and 9-2 protein complexes in living cells.
    Masuho I; Xie K; Martemyanov KA
    J Biol Chem; 2013 Aug; 288(35):25129-25142. PubMed ID: 23857581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous receptor-independent heterotrimeric G-protein signalling in an RGS mutant.
    Siekhaus DE; Drubin DG
    Nat Cell Biol; 2003 Mar; 5(3):231-5. PubMed ID: 12598904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Nuclear Magnetic Resonance Screen against a Regulator of G Protein Signaling Identifies a Binding "Hot Spot".
    Hayes MP; O'Brien JB; Crawford RA; Fowler CA; Yu L; Doorn JA; Roman DL
    Chembiochem; 2021 May; 22(9):1609-1620. PubMed ID: 33480159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.
    Dhukhwa A; Al Aameri RFH; Sheth S; Mukherjea D; Rybak L; Ramkumar V
    Sci Rep; 2021 Apr; 11(1):8116. PubMed ID: 33854102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
    Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
    Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.
    Garzón J; Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P
    Psychopharmacology (Berl); 2005 Jun; 180(1):1-11. PubMed ID: 15830230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model.
    Clark MJ; Linderman JJ; Traynor JR
    Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
    Hooks SB; Callihan P; Altman MK; Hurst JH; Ali MW; Murph MM
    Mol Cancer; 2010 Nov; 9():289. PubMed ID: 21044322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RGS proteins add to the diversity of soybean heterotrimeric G-protein signaling.
    Choudhury SR; Westfall CS; Pandey S
    Plant Signal Behav; 2012 Sep; 7(9):1114-7. PubMed ID: 22899066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits.
    Siderovski DP; Willard FS
    Int J Biol Sci; 2005; 1(2):51-66. PubMed ID: 15951850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two RGS proteins that inhibit Galpha(o) and Galpha(q) signaling in C. elegans neurons require a Gbeta(5)-like subunit for function.
    Chase DL; Patikoglou GA; Koelle MR
    Curr Biol; 2001 Feb; 11(4):222-31. PubMed ID: 11250150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.